Special items: Ovarian Cancer and Us blog best viewed in Firefox

Sunday, January 24, 2010

abstract: Toxicity of sorafenib: clinical and molecular aspects; Expert Opinion on Drug Safety

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.